Olympus has identified that the BiCOAG Hemostasis Probe may have been manufactured without the required amount of adhesive on the rear of the device’s ceramic tip. This defect could cause the ceramic tip to detach during use.
Customers are instructed to stop using the affected probes immediately and contact Olympus for return instructions.
Regulatorische Updates2. Sept. 2026•1 Min. Lesezeit
Olympus Recalls BiCOAG Hemostasis Probe Over Adhesive Defect
Olympus advises immediate discontinuation of BiCOAG Hemostasis Probe due to possible adhesive shortage causing ceramic tip detachment.
Zusammengestellt vom PharmaCountry-Team · Quelle: Health Canada
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen